1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262. 被引量：1
2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86. 被引量：1
3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184. 被引量：1
4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962. 被引量：1
5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269. 被引量：1
6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866. 被引量：1
7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179. 被引量：1
8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9. 被引量：1
9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12. 被引量：1
10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261. 被引量：1
4Yang XA,Dong XY, Qiao H, et al. Immunohistochemical analysis of the expression of FATE/BJ-HCC-2 antigen in normal and malignant tissues [J]. Lab Invest, 2005, 85 (2) .. 205-213. 被引量：1
5Yuen JW, Poon LS, Chan AS, et al. Activation of STAT3 by specific Galpha subunits and multiple Gbetagamma di- mers[J]. Int J Biochem Cell Biol,2010,42(6) : 1052-1059. 被引量：1
6Liotta LA. Gene products which play a role in cancer in- vasion and metastasisFJ:. Breast Cancer Res Treat, 1988, 11(2) : 113-124. 被引量：1
7Quesada V, Ord6fiez GR, Sdnchez LM, et al. The de- gradome database: mammalian proteases and diseases of proteolysis[J]. Nucleic Acids Res,2009,37(Database is- sue) .- D239-243. 被引量：1
8Troussard AA,Costello P, Yoganathan TN, et al. The in- tegrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 ( MMP-9 ) [J]. Oncogene, 2000,19(48) : 5444-5452. 被引量：1
